Last 12 months
Inside the activity.
1 purchase rows · 60 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 1 | 6 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 10 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 71,492 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · derivative · entry 8 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,492 shares Expires 2032-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 31,668 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · derivative · entry 7 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,668 shares Expires 2032-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
SaleCommon Stock | 210,468 | $33.56 | $7,063,306.08 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 6 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,382 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.04 - $33.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
SaleCommon Stock | 11,483 | $32.64 | $374,805.12 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 5 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,850 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 - $33.035 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
Exercise / conversionCommon Stock | 16,260 | $14.70 | $239,022.00 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 4 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
Exercise / conversionCommon Stock | 77,181 | $8.43 | $650,635.83 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 3 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
Exercise / conversionCommon Stock | 71,492 | $7.94 | $567,646.48 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 2 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 20:04 UTC |
Fromkin Andrew J.Director
|
Exercise / conversionCommon Stock | 31,668 | $4.99 | $158,023.32 |
DisclosureSEC source: 0001341896-26-000004 · wk-form4_1780085096.xml · nonDerivative · entry 1 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2026 Filed May 21, 2026 01:22 UTC |
Pande AtulDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001643071-26-000004 · wk-form4_1779326521.xml · derivative · entry 4 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,252 Underlying: Common Stock · 6,000 shares Expires 2029-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025. F2 · derivative.exercise_date: Reflects an award of stock options to purchase Common Shares that is fully vested. Read SEC document |
| May 20, 2026 Filed May 21, 2026 01:22 UTC |
Pande AtulDirector
|
SaleCommon Stock | 6,000 | $32.00 | $192,000.00 |
DisclosureSEC source: 0001643071-26-000004 · wk-form4_1779326521.xml · nonDerivative · entry 2 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,731 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025. Read SEC document |
| May 20, 2026 Filed May 21, 2026 01:22 UTC |
Pande AtulDirector
|
Exercise / conversionCommon Stock | 6,000 | $8.43 | $50,580.00 |
DisclosureSEC source: 0001643071-26-000004 · wk-form4_1779326521.xml · nonDerivative · entry 1 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:03 UTC |
Gloria MelanieChief Operating Officer
|
SaleCommon Stock | 1,698 | $32.95 | $55,949.10 |
DisclosureSEC source: 0001764013-26-000067 · wk-form4_1779480209.xml · nonDerivative · entry 3 Gloria Melanie · CIK 0001973838 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,107 F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on May 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 - $33.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:03 UTC |
Gloria MelanieChief Operating Officer
|
SaleCommon Stock | 1,168 | $32.15 | $37,551.20 |
DisclosureSEC source: 0001764013-26-000067 · wk-form4_1779480209.xml · nonDerivative · entry 2 Gloria Melanie · CIK 0001973838 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,805 F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on May 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.55 - $32.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:03 UTC |
Gloria MelanieChief Operating Officer
|
SaleCommon Stock | 249 | $30.41 | $7,572.09 |
DisclosureSEC source: 0001764013-26-000067 · wk-form4_1779480209.xml · nonDerivative · entry 1 Gloria Melanie · CIK 0001973838 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,973 F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on May 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.32 - $31.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 01, 2026 Filed May 1, 2026 22:40 UTC |
Susman Robert GrahamDirector
|
SaleCommon Stock | 2,502 | $27.17 | $67,979.34 |
DisclosureSEC source: 0001764013-26-000058 · wk-form4_1777675214.xml · nonDerivative · entry 1 Susman Robert Graham · CIK 0002065992 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,394 F1 · shares: The transaction reported on this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 - $27.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 20:07 UTC |
Girao TiagoChief Financial Officer
|
SaleCommon Stock | 25,760 | $29.62 | $763,011.20 |
DisclosureSEC source: 0001764013-26-000056 · wk-form4_1777061232.xml · nonDerivative · entry 1 Girao Tiago · CIK 0001618670 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,596 F1 · shares: On May 1, 2025, the holder was granted 208,388 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on May 5, 2025, of which 52,097 of these RSUs vested on April 21, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 20:05 UTC |
Stout Jay SChief Technology Officer
|
SaleCommon Stock | 2,754 | $29.62 | $81,573.48 |
DisclosureSEC source: 0001764013-26-000055 · wk-form4_1777061153.xml · nonDerivative · entry 1 Stout Jay S · CIK 0001702969 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,685 F1 · shares: On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on April 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 - $30.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:03 UTC |
Gloria MelanieChief Operating Officer
|
SaleCommon Stock | 8,722 | $24.83 | $216,567.26 |
DisclosureSEC source: 0001973838-26-000004 · wk-form4_1775851435.xml · nonDerivative · entry 1 Gloria Melanie · CIK 0001973838 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,222 F1 · shares: On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 19,045 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:05 UTC |
Van Tuyl ChristopherChief Legal Officer
|
SaleCommon Stock | 5,165 | $24.83 | $128,246.95 |
DisclosureSEC source: 0001779707-26-000004 · wk-form4_1775851530.xml · nonDerivative · entry 1 Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,231 F1 · shares: On April 1, 2025, the holder was granted 50,787 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 12,696 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Stout Jay SChief Technology Officer
|
SaleCommon Stock | 1,518 | $24.83 | $37,691.94 |
DisclosureSEC source: 0001702969-26-000006 · wk-form4_1775851354.xml · nonDerivative · entry 2 Stout Jay S · CIK 0001702969 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,439 F3 · shares: On April 2, 2024, the holder was granted 54,978 RSUs, as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on April 2, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:02 UTC |
Stout Jay SChief Technology Officer
|
SaleCommon Stock | 8,614 | $24.83 | $213,885.62 |
DisclosureSEC source: 0001702969-26-000006 · wk-form4_1775851354.xml · nonDerivative · entry 1 Stout Jay S · CIK 0001702969 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,957 F1 · shares: On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 19,045 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:22 UTC |
Susman Robert GrahamDirector
|
GrantStock Option (right to buy) · Derivative | 7,061 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000042 · wk-form4_1775766147.xml · derivative · entry 2 Susman Robert Graham · CIK 0002065992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 Underlying: Common Stock · 7,061 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:22 UTC |
Susman Robert GrahamDirector
|
GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000042 · wk-form4_1775766147.xml · nonDerivative · entry 1 Susman Robert Graham · CIK 0002065992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,896 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:20 UTC |
Gloria MelanieChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 121,063 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000040 · wk-form4_1775766037.xml · derivative · entry 2 Gloria Melanie · CIK 0001973838 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,063 Underlying: Common Stock · 121,063 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:20 UTC |
Gloria MelanieChief Operating Officer
|
GrantCommon Stock | 83,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000040 · wk-form4_1775766037.xml · nonDerivative · entry 1 Gloria Melanie · CIK 0001973838 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,944 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:13 UTC |
Venker EricDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 336,043 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000034 · wk-form4_1775765620.xml · derivative · entry 2 Venker Eric · CIK 0001801917 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,043 Underlying: Common Stock · 336,043 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:13 UTC |
Venker EricDirector · Chief Executive Officer
|
GrantCommon Stock | 232,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000034 · wk-form4_1775765620.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,813 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:31 UTC |
Torti FrankDirector
|
GrantStock Option (right to buy) · Derivative | 88,325 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000052 · wk-form4_1775766671.xml · derivative · entry 2 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,325 Underlying: Common Stock · 88,325 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest in substantially equal quarterly installments over two years measured from April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:31 UTC |
Torti FrankDirector
|
GrantCommon Stock | 174,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000052 · wk-form4_1775766671.xml · nonDerivative · entry 1 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,009,228 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in substantially equal quarterly installments over two years measured from April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:28 UTC |
Fromkin Andrew J.Director
|
GrantStock Option (right to buy) · Derivative | 7,061 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000050 · wk-form4_1775766526.xml · derivative · entry 2 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 Underlying: Common Stock · 7,061 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:28 UTC |
Fromkin Andrew J.Director
|
GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000050 · wk-form4_1775766526.xml · nonDerivative · entry 1 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,732 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:25 UTC |
Pande AtulDirector
|
GrantStock Option (right to buy) · Derivative | 7,061 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000046 · wk-form4_1775766313.xml · derivative · entry 3 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 Underlying: Common Stock · 7,061 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:25 UTC |
Pande AtulDirector
|
GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000046 · wk-form4_1775766313.xml · nonDerivative · entry 1 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,731 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:26 UTC |
Hughes Douglas J.Director
|
GrantStock Option (right to buy) · Derivative | 7,061 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000048 · wk-form4_1775766410.xml · derivative · entry 2 Hughes Douglas J. · CIK 0001710863 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 Underlying: Common Stock · 7,061 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:26 UTC |
Hughes Douglas J.Director
|
GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000048 · wk-form4_1775766410.xml · nonDerivative · entry 1 Hughes Douglas J. · CIK 0001710863 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,653 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:23 UTC |
Bauer JakeDirector
|
GrantStock Option (right to buy) · Derivative | 7,061 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000044 · wk-form4_1775766231.xml · derivative · entry 2 Bauer Jake · CIK 0001654909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 Underlying: Common Stock · 7,061 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:23 UTC |
Bauer JakeDirector
|
GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000044 · wk-form4_1775766231.xml · nonDerivative · entry 1 Bauer Jake · CIK 0001654909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,896 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:19 UTC |
Stout Jay SChief Technology Officer
|
GrantStock Option (right to buy) · Derivative | 96,851 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000038 · wk-form4_1775765943.xml · derivative · entry 2 Stout Jay S · CIK 0001702969 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,851 Underlying: Common Stock · 96,851 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:19 UTC |
Stout Jay SChief Technology Officer
|
GrantCommon Stock | 66,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000038 · wk-form4_1775765943.xml · nonDerivative · entry 1 Stout Jay S · CIK 0001702969 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,571 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:17 UTC |
Van Tuyl ChristopherChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 59,820 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000036 · wk-form4_1775765844.xml · derivative · entry 2 Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,820 Underlying: Common Stock · 59,820 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:17 UTC |
Van Tuyl ChristopherChief Legal Officer
|
GrantCommon Stock | 41,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000036 · wk-form4_1775765844.xml · nonDerivative · entry 1 Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,396 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:10 UTC |
Girao TiagoChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 94,002 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001764013-26-000032 · wk-form4_1775765429.xml · derivative · entry 2 Girao Tiago · CIK 0001618670 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,002 Underlying: Common Stock · 94,002 shares Expires 2036-04-07 F2 · derivative.exercise_date: These options were granted pursuant to the Plan. The shares underlying the options will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in thirty-six (36) successive substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 20:10 UTC |
Girao TiagoChief Financial Officer
|
GrantCommon Stock | 64,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-26-000032 · wk-form4_1775765429.xml · nonDerivative · entry 1 Girao Tiago · CIK 0001618670 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,356 F1 · shares: These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 20:33 UTC |
Venker EricDirector · Chief Executive Officer
|
SaleCommon Stock | 1,409 | $24.60 | $34,661.40 |
DisclosureSEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 4 Venker Eric · CIK 0001801917 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,561 F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these CVARs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.51 - $24.70 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 20:33 UTC |
Venker EricDirector · Chief Executive Officer
|
SaleCommon Stock | 12,820 | $24.04 | $308,192.80 |
DisclosureSEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 3 Venker Eric · CIK 0001801917 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,970 F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these CVARs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 - $24.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:33 UTC |
Venker EricDirector · Chief Executive Officer
|
Exercise / conversionCapped Value Appreciation Rights · Derivative | 368,750 | $0.00 Strike: $14.46 | $0.00 |
DisclosureSEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · derivative · entry 5 Venker Eric · CIK 0001801917 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,106,250 Underlying: Common Stock · 368,750 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · derivative.exercise_price: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F1 · kind: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · kind: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F1 · shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F2 · derivative.exercise_date: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F6 · derivative.exercise_date: These CVARs vest on the first date that each of (i) the Service Requirement, (ii) the Performance Requirement, and (iii) the Knock-in Requirement have been satisfied. The "Service Requirement" is satisfied as follows: (i) 25% of the CVARs vested on April 1, 2026; and (ii) the remaining 75% vests in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer or an affiliate on each such vesting date. The "Performance Requirement" is tied to the achievement of a specified clinical development activity at the Issuer, which requirement was met as of March 31, 2026. The "Knock-in Requirement" requires that the price of the Issuer's common stock at each applicable vesting date must be equal to or greater than $16.76 per share. F1 · derivative.underlying_shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · derivative.underlying_shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:33 UTC |
Venker EricDirector · Chief Executive Officer
|
Disposition to issuerCommon Stock | 334,960 | $25.10 | $8,407,496.00 |
DisclosureSEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 2 Venker Eric · CIK 0001801917 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,790 F1 · kind: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · kind: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F1 · shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F1 · price: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · price: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:33 UTC |
Venker EricDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 368,750 | $14.46 | $5,332,125.00 |
DisclosureSEC source: 0001764013-26-000024 · wk-form4_1775248378.xml · nonDerivative · entry 1 Venker Eric · CIK 0001801917 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · kind: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F1 · shares: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · shares: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. F1 · price: On July 28, 2025, the Reporting Person was granted capped value appreciation rights ("CVARs"), as previously reported in a Form 4 filed on July 30, 2025, that entitle the Reporting Person to receive a payment equal to the product of (i) the number of vested CVARs multiplied by (ii) the excess (if any) of (A) the fair market value of the Issuer's common stock (capped at $16.76 per share) as of the relevant date of determination over (B) the applicable hurdle price of $14.46 (the "CVAR Amount"). The CVARs will then settle into a number of shares of common stock of the Issuer determined by dividing (i) the CVAR Amount by (ii) the fair market value of the Issuer's common stock as of such date. F2 · price: On April 1, 2026, the Service Requirement (as defined in Footnote 6), Performance Requirement (as defined in Footnote 6), Knock-In Requirement (as defined in Footnote 6), and hurdle price applicable to 368,750 vested CVARs were satisfied and, accordingly, the CVARs were settled into shares of the Issuer's common stock, determined by dividing (i) the CVAR Amount by (ii) the closing price of a share of the Issuer's common stock on April 1, 2026. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 20:11 UTC |
Van Tuyl ChristopherChief Legal Officer
|
SaleCommon Stock | 2,877 | $24.97 | $71,838.69 |
DisclosureSEC source: 0001764013-26-000015 · wk-form4_1774037475.xml · nonDerivative · entry 1 Van Tuyl Christopher · CIK 0001779707 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,053 F1 · shares: On December 16, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on December 18, 2024, of which 6,872 of these RSUs vested on March 16, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:07 UTC |
Gloria MelanieChief Operating Officer
|
SaleCommon Stock | 942 | $28.90 | $27,223.80 |
DisclosureSEC source: 0001764013-26-000013 · wk-form4_1772226458.xml · nonDerivative · entry 3 Gloria Melanie · CIK 0001973838 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,273 F1 · shares: On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on February 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.70 - $29.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.